Evaluation of the Relationship Between Androgenetic Alopecia and Blood Groups and Rhesus Factor

August 2020 in “ International Journal of Clinical Practice ”

Nihal Altunisik, Dursun Turkmen, Burcu Kayhan Tetik, Serpil Sener

androgenetic alopecia AGA androgen levels cardiovascular diseases metabolic syndrome diabetes androgenic alopecia

Studysummary In this study, researchers found no statistically significant difference in blood group distribution between patients with androgenetic alopecia and a healthy population.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

A study with 207 patients with androgenetic alopecia (AGA) and 642 healthy individuals found no significant difference in blood groups and Rhesus factor between the two groups, concluding that there is no relationship between AGA and blood groups or Rhesus factor. AGA is a hair loss condition influenced by androgen levels, age, and genetics, and may also be linked to systemic diseases such as cardiovascular diseases, metabolic syndrome, and diabetes.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

research Clinical Profile of Androgenic Alopecia and Its Association with Cardiovascular Risk Factors

13 citations , January 2019 in “Indian Journal of Dermatology”

This study found that men with early-onset androgenic alopecia had a higher prevalence of cardiovascular risk factors, indicating that early screening for metabolic syndrome may be beneficial in this population.

An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia

research An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia

12 citations , June 2017 in “Cell Cycle”

This study observed that 5% minoxidil topical foam alters gene expression and signaling pathways in the scalp, providing insights into its mechanism of action in men with androgenetic alopecia.

research Androgenetic Alopecia as an Indicator of Metabolic Syndrome and Cardiovascular Risk

13 citations , November 2015 in “Blood Pressure”

This study found that early-onset androgenetic alopecia, especially with a vertex pattern, may be an independent risk factor for cardiovascular disease and metabolic syndrome in men.

research Male Androgenetic Alopecia

3 citations , March 2014 in “Turkderm”

This article reviews the causes, clinical features, and treatment options for androgenetic alopecia, but provides no new clinical findings.

research Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study

56 citations , June 2001 in “European journal of cardiovascular prevention & rehabilitation”

This study found that men with early-onset androgenic alopecia have a higher risk of needing coronary revascularization before age 60 compared to those with later onset or no hair loss.

research Androgenetic Alopecia in Heterozygous Carriers of a Mutation in the Human Hairless Gene

9 citations , June 2000 in “Journal of The American Academy of Dermatology”

This study reported that heterozygous carriers of a mutation in the human hairless gene did not differ from healthy homozygotes in the pattern of androgenetic alopecia.